Nanobody‐Modified Outer Membrane Vesicles Attenuate Alzheimer's Disease‐Like Neurodegeneration by Modulating Mitophagy‐Associated Phenotypes and cGAS‐STING‐Related Inflammatory Signaling
Advanced Healthcare Materials · 02.11.2026
DOI: 10.1002/adhm.71891 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 02.11.2026. Verfasst von Jiannan Xiao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Affiliated Yongchuan Hospital of Chongqing Medical University, General Practice School of Chongqing Medical Universit…. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Chongqing Science-Health Joint Medical Research Project.
Themen: Demenz
Abstract (Originalsprache)
This study examined anti‐transferrin receptor (TfR) nanobody‐functionalized bacterial outer membrane vesicles (OMVs) as an engineered platform for improving Alzheimer's disease (AD)‐like neuronal injury. Escherichia coli‐derived OMVs were characterized for morphology, size distribution, surface charge, protein features, nanobody loading, residual endotoxin levels, endotoxin‐associated inflammatory responses, and repeated‐exposure immune‐safety readouts, and were evaluated in neuronal‐related cells and APP/PS1 mice. Engineered OMVs showed receptor‐associated uptake and preferential brain‐delivery signals, increased HT‐22 cell viability, reduced apoptosis, and elevated mitophagy‐associated markers including LC3‐II, PINK1, and Parkin. OMV treatment also reduced cytosolic mtDNA abundance, DNA/cGAS colocalization, phosphorylation of STING/TBK1/IRF3, and inflammatory‐marker expression. PINK1 or Parkin knockdown partially weakened OMV‐associated mitochondrial and inflammatory readouts, whereas pharmacological autophagy modulation supported a contribution of autophagy‐related processes without establishing selective PINK1/Parkin‐dependent mitophagy in vivo. In APP/PS1 mice, OMV administration improved Morris water maze and rotarod performance and alleviated neuroinflammatory and histological injury‐related changes. Overall, anti‐TfR nanobody‐modified OMVs were associated with enhanced receptor‐related delivery, mitophagy‐linked phenotypes, reduced cytosolic mtDNA/cGAS‐STING‐related inflammatory signaling, and improved AD‐like outcomes, supporting further delivery‐system optimization and mechanistic validation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, The Affiliated Yongchuan Hospital of Chongqing Medical University, General Practice School of Chongqing Medical University, Chongqing, China.
- Department of Neurology, The Affiliated Yongchuan Hospital of Chongqing Medical University, Chongqing, China.
- Department of Pathology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.
Förderung
- Chongqing Science-Health Joint Medical Research Project
Zitieren
APA
Xiao, J., Yang, Z., Li, J., Xiong, Q., Xia, X., Hao, L., Ling, Z., Pang, K., Zhou, C., & Wu, H. (2026). Nanobody‐Modified Outer Membrane Vesicles Attenuate Alzheimer's Disease‐Like Neurodegeneration by Modulating Mitophagy‐Associated Phenotypes and cGAS‐STING‐Related Inflammatory Signaling. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71891
Vancouver
Xiao J, Yang Z, Li J, Xiong Q, Xia X, Hao L, et al. Nanobody‐Modified Outer Membrane Vesicles Attenuate Alzheimer's Disease‐Like Neurodegeneration by Modulating Mitophagy‐Associated Phenotypes and cGAS‐STING‐Related Inflammatory Signaling. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71891
BibTeX
@article{Xiao2026,
author = {Xiao, Jiannan and Yang, Zhao and Li, Juan and Xiong, Qijiang and Xia, Xiaohui and Hao, Lei and Ling, Zefa and Pang, Ke and Zhou, Changlong and Wu, He},
title = {Nanobody‐Modified Outer Membrane Vesicles Attenuate Alzheimer's Disease‐Like Neurodegeneration by Modulating Mitophagy‐Associated Phenotypes and cGAS‐STING‐Related Inflammatory Signaling},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71891}
}
EUVIMED